Improving the Impact and Effectiveness of the National Vaccine Advisory Committee
ResearchPublished Sep 28, 2009
The National Vaccine Advisory Committee (NVAC) was established by the National Childhood Vaccine Injury Act of 1986 to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. There is wide consensus, however, that NVAC has not achieved its potential. This report seeks to identify the reasons the committee has not had a greater impact and suggests strategies to improve its effectiveness. The authors conducted a review of the literature on advisory committees, reviewed recommendations made by NVAC since 1998 with a focus on their characteristics, and conducted a series of interviews with key informants. Among the report’s findings: NVAC should proactively seek input regarding priority vaccine and immunization issues. Its recommendations should be written in a manner specific enough to be easily actionable, and it should monitor the status of those recommendations on a regular basis. Finally, it should think more strategically about its dissemination efforts, clearly delineating the intended audiences and identifying innovative and effective ways to reach them.
Topics
Document Details
- Copyright: RAND Corporation
- Availability: Web-Only
- Year: 2009
- Pages: 43
- Document Number: TR-752-DHHS
Citation
RAND Style Manual
Chicago Manual of Style
Ringel, Jeanne S., Marisa Adelson, Katherine M. Harris, Dmitry Khodyakov, and Nicole Lurie, Improving the Impact and Effectiveness of the National Vaccine Advisory Committee, RAND Corporation, TR-752-DHHS, 2009. As of October 11, 2024: https://www.rand.org/pubs/technical_reports/TR752.html
Ringel, Jeanne S., Marisa Adelson, Katherine M. Harris, Dmitry Khodyakov, and Nicole Lurie, Improving the Impact and Effectiveness of the National Vaccine Advisory Committee. Santa Monica, CA: RAND Corporation, 2009. https://www.rand.org/pubs/technical_reports/TR752.html.
The research in this report was prepared for the U.S. Department of Health and Human Services National Vaccine Program Office. and conducted by RAND Health.
This publication is part of the RAND technical report series. RAND technical reports, products of RAND from 2003 to 2011, presented research findings on a topic limited in scope or intended for a narrow audience; discussions of the methodology employed in research; literature reviews, survey instruments, modeling exercises, guidelines for practitioners and research professionals, and supporting documentation; and preliminary findings. All RAND technical reports were subject to rigorous peer review to ensure high standards for research quality and objectivity.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.